NexgenRx Inc.
NXG.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.43% | 93.09% | 212.21% | 464.06% | 137.27% |
| Total Depreciation and Amortization | -7.48% | 11.55% | -5.41% | -5.99% | -3.19% |
| Total Amortization of Deferred Charges | -- | -9.14% | -- | -- | -- |
| Total Other Non-Cash Items | -26.76% | 336.55% | -83.02% | 7.87% | -39.22% |
| Change in Net Operating Assets | 65.53% | -229.64% | -158.76% | 109.59% | -34.89% |
| Cash from Operations | 162.92% | -41.12% | -81.62% | 56.84% | -18.44% |
| Capital Expenditure | -72.99% | -136.78% | 85.89% | -435.71% | -191.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.50% | -- | -- | 26.59% | -- |
| Cash from Investing | -48.33% | -2,198.85% | -24.18% | 11.85% | -855.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -64.25% | -13.55% | -53.18% | -39.31% | -19.65% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.12% | 76.34% | 1.63% | 8.88% | -0.41% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -188.28% | 78.22% | -341.76% | 14.52% | 242.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.61% | -123.15% | -94.84% | 8,305.13% | -2.93% |